ES2168285T3 - Agentes endoparasiticidas que contienen praziquantel y epsiprantel. - Google Patents

Agentes endoparasiticidas que contienen praziquantel y epsiprantel.

Info

Publication number
ES2168285T3
ES2168285T3 ES94120772T ES94120772T ES2168285T3 ES 2168285 T3 ES2168285 T3 ES 2168285T3 ES 94120772 T ES94120772 T ES 94120772T ES 94120772 T ES94120772 T ES 94120772T ES 2168285 T3 ES2168285 T3 ES 2168285T3
Authority
ES
Spain
Prior art keywords
epsiprantel
endoparasiticid
agents containing
praziquantel
containing praziquantel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94120772T
Other languages
English (en)
Spanish (es)
Inventor
Norbert Dr Mencke
Achim Dr Harder
Peter Dr Jeschke
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Application granted granted Critical
Publication of ES2168285T3 publication Critical patent/ES2168285T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/15—Depsipeptides; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N33/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic nitrogen compounds
    • A01N33/02—Amines; Quaternary ammonium compounds
    • A01N33/04—Nitrogen directly attached to aliphatic or cycloaliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Luminescent Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Peptides Or Proteins (AREA)
  • Compositions Of Oxide Ceramics (AREA)
  • Cosmetics (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
ES94120772T 1994-01-11 1994-12-27 Agentes endoparasiticidas que contienen praziquantel y epsiprantel. Expired - Lifetime ES2168285T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4400464A DE4400464A1 (de) 1994-01-11 1994-01-11 Endoparasitizide Mittel

Publications (1)

Publication Number Publication Date
ES2168285T3 true ES2168285T3 (es) 2002-06-16

Family

ID=6507651

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94120772T Expired - Lifetime ES2168285T3 (es) 1994-01-11 1994-12-27 Agentes endoparasiticidas que contienen praziquantel y epsiprantel.

Country Status (27)

Country Link
US (1) US5589503A (en, 2012)
EP (1) EP0662326B1 (en, 2012)
JP (2) JP4033920B2 (en, 2012)
KR (1) KR100359618B1 (en, 2012)
CN (1) CN1165338C (en, 2012)
AT (1) ATE209501T1 (en, 2012)
AU (1) AU685535B2 (en, 2012)
CA (1) CA2139725C (en, 2012)
CZ (1) CZ290246B6 (en, 2012)
DE (3) DE4400464A1 (en, 2012)
DK (1) DK0662326T5 (en, 2012)
ES (1) ES2168285T3 (en, 2012)
FI (1) FI116885B (en, 2012)
FR (1) FR06C0002I2 (en, 2012)
HU (1) HU226207B1 (en, 2012)
IL (1) IL112285A (en, 2012)
NL (1) NL300218I2 (en, 2012)
NO (2) NO307030B1 (en, 2012)
NZ (1) NZ270300A (en, 2012)
PH (1) PH31462A (en, 2012)
PL (1) PL180019B1 (en, 2012)
PT (1) PT662326E (en, 2012)
RU (1) RU2124364C1 (en, 2012)
SK (1) SK283367B6 (en, 2012)
TW (1) TW364850B (en, 2012)
UA (1) UA41327C2 (en, 2012)
ZA (1) ZA95136B (en, 2012)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4317458A1 (de) * 1992-06-11 1993-12-16 Bayer Ag Verwendung von cyclischen Depsipeptiden mit 18 Ringatomen zur Bekämpfung von Endoparasiten, neue cyclische Depsipeptide mit 18 Ringatomen und Verfahren zu ihrer Herstellung
DE19520275A1 (de) * 1995-06-02 1996-12-05 Bayer Ag Endoparasitizide Mittel
RU2203665C2 (ru) * 1997-10-20 2003-05-10 Дайниппон Фармасьютикал Ко., Лтд. Быстрорастворяющаяся фармацевтическая композиция
DE19921887A1 (de) * 1999-05-12 2000-11-16 Bayer Ag Endoparasitizide Mittel
DE10008128A1 (de) * 2000-02-22 2001-08-23 Bayer Ag Endoparasitizide Mittel
KR100358084B1 (ko) * 2000-10-04 2002-10-25 주식회사대성미생물연구소 프라지콴텔과 시메티딘 합제를 이용한 어류의아가미흡충증 치료방법
DE10104362A1 (de) * 2001-02-01 2002-08-08 Bayer Ag Kristallmodifikation eines cyclischen Depsipeptids mit besserer Wirksamkeit
JP4140523B2 (ja) * 2001-06-28 2008-08-27 日本ゼオン株式会社 有機金属反応方法
BR0213124A (pt) * 2001-10-05 2004-09-21 Rubicon Scient Llc Alimentos para animais incluindo ativos e métodos de uso dos mesmos
DE10358525A1 (de) 2003-12-13 2005-07-07 Bayer Healthcare Ag Endoparasitizide Mittel zur topischen Applikation
DE10359798A1 (de) * 2003-12-19 2005-07-21 Bayer Healthcare Ag Cyclohexadepsipeptide zur Bekämpfung von Endoparasiten und ein Verfahren zu ihrer Herstellung
DE102004055316A1 (de) * 2004-11-16 2006-05-18 Bayer Healthcare Ag Verhinderung vertikaler Endoparasiten-Infektionen
DE102005011779A1 (de) * 2005-03-11 2006-09-14 Bayer Healthcare Ag Endoparasitizide Mittel
CA2733795C (en) * 2008-08-28 2013-12-31 Pfizer Inc. Dioxa-bicyclo[3.2.1.]octane-2,3,4-triol derivatives
DE102009012423A1 (de) 2009-03-10 2010-09-16 Bayer Animal Health Gmbh Zubereitung auf Ölbasis
CN108524480A (zh) * 2011-03-02 2018-09-14 国立大学法人东京大学 体内寄生虫防除剂
DK2782565T3 (da) * 2011-11-25 2020-01-02 Bayer Ip Gmbh Anvendelse af aryl- og hetarylcarboxamider som endoparasiticider
TWI693237B (zh) * 2015-05-20 2020-05-11 美商百靈佳殷格翰動物保健美國有限公司 驅蟲酯肽化合物
HUE065907T2 (hu) * 2015-12-28 2024-06-28 Boehringer Ingelheim Vetmedica Gmbh Anthelmintikus hatású depszipeptid vegyületek
CA3044038A1 (en) 2016-11-16 2018-05-24 Boehringer Ingelheim Animal Health USA Inc. Anthelmintic depsipeptide compounds
WO2021028479A1 (en) 2019-08-14 2021-02-18 Vetoquinol S.A. Compositions comprising tigolaner for controlling parasites
CN113943350B (zh) * 2021-11-02 2023-08-15 海南大学三亚南繁研究院 一种环肽化合物或其药学上可接受的盐及其制备方法和应用、药物及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO176766C (no) * 1989-02-07 1995-05-24 Meiji Seika Kaisha Fremgangsmåte for fremstilling av en forbindelse med anthelmintaktivitet
GB9024924D0 (en) * 1990-11-16 1991-01-02 Beecham Group Plc Novel compositions
NZ247278A (en) * 1991-02-12 1995-03-28 Ancare Distributors Veterinary anthelmintic drench comprising a suspension of praziquantel in a liquid carrier
AU669883B2 (en) * 1992-03-17 1996-06-27 Astellas Pharma Inc. Depsipeptide derivative, production thereof and use thereof
DE4317458A1 (de) * 1992-06-11 1993-12-16 Bayer Ag Verwendung von cyclischen Depsipeptiden mit 18 Ringatomen zur Bekämpfung von Endoparasiten, neue cyclische Depsipeptide mit 18 Ringatomen und Verfahren zu ihrer Herstellung
WO1994019334A1 (en) * 1993-02-19 1994-09-01 Meiji Seika Kaisha, Ltd. Pf1022 derivative, cyclic depsipeptide
DE4317457A1 (de) * 1993-05-26 1994-12-01 Bayer Ag Octacyclodepsipeptide mit endoparasitizider Wirkung
DE4317432A1 (de) * 1993-05-26 1994-12-01 Bayer Ag Octacyclodepsipeptide mit endoparasitizider Wirkung

Also Published As

Publication number Publication date
DK0662326T3 (da) 2002-03-18
AU8159294A (en) 1995-07-20
FI950091A0 (fi) 1995-01-09
EP0662326B1 (de) 2001-11-28
NZ270300A (en) 1995-09-26
TW364850B (en) 1999-07-21
NO307030B1 (no) 2000-01-31
NO2006001I2 (no) 2008-02-04
RU95100759A (ru) 1997-03-20
SK3195A3 (en) 1995-08-09
FR06C0002I2 (en, 2012) 2006-12-29
HU226207B1 (en) 2008-06-30
PH31462A (en) 1998-11-03
CA2139725C (en) 2005-01-04
DE4400464A1 (de) 1995-07-13
AU685535B2 (en) 1998-01-22
UA41327C2 (uk) 2001-09-17
EP0662326A3 (de) 1997-12-17
EP0662326A2 (de) 1995-07-12
NL300218I1 (nl) 2006-04-03
FI950091L (fi) 1995-07-12
HUT69180A (en) 1995-08-28
CN1165338C (zh) 2004-09-08
PL306709A1 (en) 1995-07-24
DE59409977D1 (de) 2002-01-10
IL112285A (en) 1999-06-20
JPH07223951A (ja) 1995-08-22
KR950031104A (ko) 1995-12-18
SK283367B6 (sk) 2003-06-03
DK0662326T5 (da) 2008-11-03
CZ290246B6 (cs) 2002-06-12
PL180019B1 (pl) 2000-12-29
NO950093D0 (no) 1995-01-10
CN1121429A (zh) 1996-05-01
IL112285A0 (en) 1995-03-30
JP2007314580A (ja) 2007-12-06
FI116885B (fi) 2006-03-31
DE122006000001I2 (de) 2007-05-24
KR100359618B1 (ko) 2003-01-29
CA2139725A1 (en) 1995-07-12
CZ6195A3 (en) 1995-07-12
ZA95136B (en) 1995-09-07
FR06C0002I1 (en, 2012) 2006-03-10
RU2124364C1 (ru) 1999-01-10
US5589503A (en) 1996-12-31
NO2006001I1 (no) 2006-02-13
PT662326E (pt) 2002-05-31
NL300218I2 (nl) 2006-07-03
JP4033920B2 (ja) 2008-01-16
NO950093L (no) 1995-07-12
ATE209501T1 (de) 2001-12-15
DE122006000001I1 (de) 2006-05-04

Similar Documents

Publication Publication Date Title
ES2168285T3 (es) Agentes endoparasiticidas que contienen praziquantel y epsiprantel.
ES2169258T3 (es) Utilizacion de proteasa de subtilisina mutada en productos cosmeticos.
ES2124638T3 (es) Composicion cosmetica que comprende un polimero fijante y un almidon anfotero.
AR009626A1 (es) Una composicion dermatologica o cosmetica que comprende una cantidad de esfingomielinasa efectiva para producir un aumento en el nivel de las ceramidas de la piel y de la mucosa.
BR9807564A (pt) Sistema de barbear a úmido.
ES2183186T3 (es) Composiciones cosmeticas en polvo que contienen elastomeros de silicona.
ES2157131T3 (es) Utilizacion del 1,2-pentanodiol en una composicion cosmetica o dermatologica que contiene una dispersion acuosa de polimero filmogeno, y composicion cosmetica o dermatologica que comprende estos constituyentes.
ES2060983T3 (es) Utilizacion en cosmetica de una dispersion acuosa a base de organopolisilosanos y un copolimero de acrilato de amonio/acrilamida reticulados.
ES2176700T3 (es) Composiciones para la piel.
ES2099643T3 (es) Composicion para uso topico que contiene un antioxidante y un extracto bacteriano.
ES2102275T3 (es) Composicion cosmetica o dermatologica que contiene una mezcla de ceramidas, su utilizacion para hidratar la piel.
AR022148A1 (es) ARTíCULO ABSORBENTE Y MÉTODO PARA FABRICAR UNA ESTRUCTURA ABSORBENTE.
BR9902191A (pt) Artigo absorvente
CO5011037A1 (es) Metodo para mejorar la condicion de la piel de un usuario en el area cubierta por un articulo absorbente
MX9700538A (es) Uso de droloxifeno y sus sales farmaceuticamente aceptables en la preparacion de remedios para las enfermedades cardiovasculares.
ES2171971T3 (es) Producto limpiador y de tratamiento con almidon.
DE60106954D1 (de) Resorcin-derivate
AR005940A1 (es) Composicion cosmetica de fijacion y brillo en aerosol, y procedimiento
BR0114059A (pt) Derivados de resorcinol
BR0210013A (pt) Gel oftálmico de pirenzepina
MX9300550A (es) Estructura de fibra absorbente.
AR026490A1 (es) Composiciones cosmeticas que contienen extracto de garbanzo en combinacion con retinoides y metodo cosmetico de aplicacion de dicha composicion
ES2167852T3 (es) Utilizacion de derivados oxamato como agentes despigmentantes.
TR200001040T2 (tr) Kaşıntıyı önleme etkisi için bileşiklerin yeni bir kullanımı
AR003901A1 (es) Composicion para el tratamiento de las fibras queratinicas que comprende al menos un polimero fijante y al menos un compuesto de tipo ceramida yprocedimientos.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 662326

Country of ref document: ES